img

Global Biologic Medical Product Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Biologic Medical Product Market Insights, Forecast to 2034

Biological products include a wide range of products such as vaccines, blood and blood components, allergenics, somatic cells, gene therapy, tissues, and recombinant therapeutic proteins. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living entities such as cells and tissues. Biologics are isolated from a variety of natural sources - human, animal, or microorganism - and may be produced by biotechnology methods and other cutting-edge technologies. Gene-based and cellular biologics, for example, often are at the forefront of biomedical research, and may be used to treat a variety of medical conditions for which no other treatments are available.
Market Analysis and InsightsGlobal Biologic Medical Product Market
Global Biologic Medical Product market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Biologic Medical Product industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Biologic Medical Product market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Biologic Medical Product market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Roche
Amgen
AbbVie
Pfizer
Sanofi-Aventis
Johnson & Johnson
Novo Nordisk
Eli Lilly
Novartis
Merck
Sun
3sbio
Changchun High Tech
CP Guojian
Biotech
Gelgen
Innovent
Ganlee
United Laboratories
Teva Pharmaceutical
MYLAN
Sun Pharma
Segment by Type
Monoclonal Antibodies
Colony-Stimulating Factor
Interferon
Erythropoietin
Insulin
Vaccines
Growth Hormones
Others

Segment by Application


Tumor
Diabetes
Cardiovascular
Hemophilia
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Biologic Medical Product introduction, etc. Biologic Medical Product Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Biologic Medical Product
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biologic Medical Product Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Monoclonal Antibodies
1.2.3 Colony-Stimulating Factor
1.2.4 Interferon
1.2.5 Erythropoietin
1.2.6 Insulin
1.2.7 Vaccines
1.2.8 Growth Hormones
1.2.9 Others
1.3 Market by Application
1.3.1 Global Biologic Medical Product Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Tumor
1.3.3 Diabetes
1.3.4 Cardiovascular
1.3.5 Hemophilia
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biologic Medical Product Market Perspective (2018-2029)
2.2 Global Biologic Medical Product Growth Trends by Region
2.2.1 Biologic Medical Product Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Biologic Medical Product Historic Market Size by Region (2018-2024)
2.2.3 Biologic Medical Product Forecasted Market Size by Region (2024-2029)
2.3 Biologic Medical Product Market Dynamics
2.3.1 Biologic Medical Product Industry Trends
2.3.2 Biologic Medical Product Market Drivers
2.3.3 Biologic Medical Product Market Challenges
2.3.4 Biologic Medical Product Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Biologic Medical Product by Players
3.1.1 Global Biologic Medical Product Revenue by Players (2018-2024)
3.1.2 Global Biologic Medical Product Revenue Market Share by Players (2018-2024)
3.2 Global Biologic Medical Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Biologic Medical Product, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Biologic Medical Product Market Concentration Ratio
3.4.1 Global Biologic Medical Product Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biologic Medical Product Revenue in 2022
3.5 Global Key Players of Biologic Medical Product Head office and Area Served
3.6 Global Key Players of Biologic Medical Product, Product and Application
3.7 Global Key Players of Biologic Medical Product, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Biologic Medical Product Breakdown Data by Type
4.1 Global Biologic Medical Product Historic Market Size by Type (2018-2024)
4.2 Global Biologic Medical Product Forecasted Market Size by Type (2024-2029)
5 Biologic Medical Product Breakdown Data by Application
5.1 Global Biologic Medical Product Historic Market Size by Application (2018-2024)
5.2 Global Biologic Medical Product Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Biologic Medical Product Market Size (2018-2029)
6.2 North America Biologic Medical Product Market Size by Type
6.2.1 North America Biologic Medical Product Market Size by Type (2018-2024)
6.2.2 North America Biologic Medical Product Market Size by Type (2024-2029)
6.2.3 North America Biologic Medical Product Market Share by Type (2018-2029)
6.3 North America Biologic Medical Product Market Size by Application
6.3.1 North America Biologic Medical Product Market Size by Application (2018-2024)
6.3.2 North America Biologic Medical Product Market Size by Application (2024-2029)
6.3.3 North America Biologic Medical Product Market Share by Application (2018-2029)
6.4 North America Biologic Medical Product Market Size by Country
6.4.1 North America Biologic Medical Product Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Biologic Medical Product Market Size by Country (2018-2024)
6.4.3 North America Biologic Medical Product Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Biologic Medical Product Market Size (2018-2029)
7.2 Europe Biologic Medical Product Market Size by Type
7.2.1 Europe Biologic Medical Product Market Size by Type (2018-2024)
7.2.2 Europe Biologic Medical Product Market Size by Type (2024-2029)
7.2.3 Europe Biologic Medical Product Market Share by Type (2018-2029)
7.3 Europe Biologic Medical Product Market Size by Application
7.3.1 Europe Biologic Medical Product Market Size by Application (2018-2024)
7.3.2 Europe Biologic Medical Product Market Size by Application (2024-2029)
7.3.3 Europe Biologic Medical Product Market Share by Application (2018-2029)
7.4 Europe Biologic Medical Product Market Size by Country
7.4.1 Europe Biologic Medical Product Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Biologic Medical Product Market Size by Country (2018-2024)
7.4.3 Europe Biologic Medical Product Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Biologic Medical Product Market Size (2018-2029)
8.2 China Biologic Medical Product Market Size by Type
8.2.1 China Biologic Medical Product Market Size by Type (2018-2024)
8.2.2 China Biologic Medical Product Market Size by Type (2024-2029)
8.2.3 China Biologic Medical Product Market Share by Type (2018-2029)
8.3 China Biologic Medical Product Market Size by Application
8.3.1 China Biologic Medical Product Market Size by Application (2018-2024)
8.3.2 China Biologic Medical Product Market Size by Application (2024-2029)
8.3.3 China Biologic Medical Product Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Biologic Medical Product Market Size (2018-2029)
9.2 Asia Biologic Medical Product Market Size by Type
9.2.1 Asia Biologic Medical Product Market Size by Type (2018-2024)
9.2.2 Asia Biologic Medical Product Market Size by Type (2024-2029)
9.2.3 Asia Biologic Medical Product Market Share by Type (2018-2029)
9.3 Asia Biologic Medical Product Market Size by Application
9.3.1 Asia Biologic Medical Product Market Size by Application (2018-2024)
9.3.2 Asia Biologic Medical Product Market Size by Application (2024-2029)
9.3.3 Asia Biologic Medical Product Market Share by Application (2018-2029)
9.4 Asia Biologic Medical Product Market Size by Region
9.4.1 Asia Biologic Medical Product Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Biologic Medical Product Market Size by Region (2018-2024)
9.4.3 Asia Biologic Medical Product Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Biologic Medical Product Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Biologic Medical Product Market Size by Type
10.2.1 Middle East, Africa, and Latin America Biologic Medical Product Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Biologic Medical Product Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Biologic Medical Product Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Biologic Medical Product Market Size by Application
10.3.1 Middle East, Africa, and Latin America Biologic Medical Product Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Biologic Medical Product Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Biologic Medical Product Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Biologic Medical Product Market Size by Country
10.4.1 Middle East, Africa, and Latin America Biologic Medical Product Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Biologic Medical Product Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Biologic Medical Product Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Biologic Medical Product Introduction
11.1.4 Roche Revenue in Biologic Medical Product Business (2018-2024)
11.1.5 Roche Recent Developments
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Biologic Medical Product Introduction
11.2.4 Amgen Revenue in Biologic Medical Product Business (2018-2024)
11.2.5 Amgen Recent Developments
11.3 AbbVie
11.3.1 AbbVie Company Details
11.3.2 AbbVie Business Overview
11.3.3 AbbVie Biologic Medical Product Introduction
11.3.4 AbbVie Revenue in Biologic Medical Product Business (2018-2024)
11.3.5 AbbVie Recent Developments
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Biologic Medical Product Introduction
11.4.4 Pfizer Revenue in Biologic Medical Product Business (2018-2024)
11.4.5 Pfizer Recent Developments
11.5 Sanofi-Aventis
11.5.1 Sanofi-Aventis Company Details
11.5.2 Sanofi-Aventis Business Overview
11.5.3 Sanofi-Aventis Biologic Medical Product Introduction
11.5.4 Sanofi-Aventis Revenue in Biologic Medical Product Business (2018-2024)
11.5.5 Sanofi-Aventis Recent Developments
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Biologic Medical Product Introduction
11.6.4 Johnson & Johnson Revenue in Biologic Medical Product Business (2018-2024)
11.6.5 Johnson & Johnson Recent Developments
11.7 Novo Nordisk
11.7.1 Novo Nordisk Company Details
11.7.2 Novo Nordisk Business Overview
11.7.3 Novo Nordisk Biologic Medical Product Introduction
11.7.4 Novo Nordisk Revenue in Biologic Medical Product Business (2018-2024)
11.7.5 Novo Nordisk Recent Developments
11.8 Eli Lilly
11.8.1 Eli Lilly Company Details
11.8.2 Eli Lilly Business Overview
11.8.3 Eli Lilly Biologic Medical Product Introduction
11.8.4 Eli Lilly Revenue in Biologic Medical Product Business (2018-2024)
11.8.5 Eli Lilly Recent Developments
11.9 Novartis
11.9.1 Novartis Company Details
11.9.2 Novartis Business Overview
11.9.3 Novartis Biologic Medical Product Introduction
11.9.4 Novartis Revenue in Biologic Medical Product Business (2018-2024)
11.9.5 Novartis Recent Developments
11.10 Merck
11.10.1 Merck Company Details
11.10.2 Merck Business Overview
11.10.3 Merck Biologic Medical Product Introduction
11.10.4 Merck Revenue in Biologic Medical Product Business (2018-2024)
11.10.5 Merck Recent Developments
11.11 Sun
11.11.1 Sun Company Details
11.11.2 Sun Business Overview
11.11.3 Sun Biologic Medical Product Introduction
11.11.4 Sun Revenue in Biologic Medical Product Business (2018-2024)
11.11.5 Sun Recent Developments
11.12 3sbio
11.12.1 3sbio Company Details
11.12.2 3sbio Business Overview
11.12.3 3sbio Biologic Medical Product Introduction
11.12.4 3sbio Revenue in Biologic Medical Product Business (2018-2024)
11.12.5 3sbio Recent Developments
11.13 Changchun High Tech
11.13.1 Changchun High Tech Company Details
11.13.2 Changchun High Tech Business Overview
11.13.3 Changchun High Tech Biologic Medical Product Introduction
11.13.4 Changchun High Tech Revenue in Biologic Medical Product Business (2018-2024)
11.13.5 Changchun High Tech Recent Developments
11.14 CP Guojian
11.14.1 CP Guojian Company Details
11.14.2 CP Guojian Business Overview
11.14.3 CP Guojian Biologic Medical Product Introduction
11.14.4 CP Guojian Revenue in Biologic Medical Product Business (2018-2024)
11.14.5 CP Guojian Recent Developments
11.15 Biotech
11.15.1 Biotech Company Details
11.15.2 Biotech Business Overview
11.15.3 Biotech Biologic Medical Product Introduction
11.15.4 Biotech Revenue in Biologic Medical Product Business (2018-2024)
11.15.5 Biotech Recent Developments
11.16 Gelgen
11.16.1 Gelgen Company Details
11.16.2 Gelgen Business Overview
11.16.3 Gelgen Biologic Medical Product Introduction
11.16.4 Gelgen Revenue in Biologic Medical Product Business (2018-2024)
11.16.5 Gelgen Recent Developments
11.17 Innovent
11.17.1 Innovent Company Details
11.17.2 Innovent Business Overview
11.17.3 Innovent Biologic Medical Product Introduction
11.17.4 Innovent Revenue in Biologic Medical Product Business (2018-2024)
11.17.5 Innovent Recent Developments
11.18 Ganlee
11.18.1 Ganlee Company Details
11.18.2 Ganlee Business Overview
11.18.3 Ganlee Biologic Medical Product Introduction
11.18.4 Ganlee Revenue in Biologic Medical Product Business (2018-2024)
11.18.5 Ganlee Recent Developments
11.19 United Laboratories
11.19.1 United Laboratories Company Details
11.19.2 United Laboratories Business Overview
11.19.3 United Laboratories Biologic Medical Product Introduction
11.19.4 United Laboratories Revenue in Biologic Medical Product Business (2018-2024)
11.19.5 United Laboratories Recent Developments
11.20 Teva Pharmaceutical
11.20.1 Teva Pharmaceutical Company Details
11.20.2 Teva Pharmaceutical Business Overview
11.20.3 Teva Pharmaceutical Biologic Medical Product Introduction
11.20.4 Teva Pharmaceutical Revenue in Biologic Medical Product Business (2018-2024)
11.20.5 Teva Pharmaceutical Recent Developments
11.21 MYLAN
11.21.1 MYLAN Company Details
11.21.2 MYLAN Business Overview
11.21.3 MYLAN Biologic Medical Product Introduction
11.21.4 MYLAN Revenue in Biologic Medical Product Business (2018-2024)
11.21.5 MYLAN Recent Developments
11.22 Sun Pharma
11.22.1 Sun Pharma Company Details
11.22.2 Sun Pharma Business Overview
11.22.3 Sun Pharma Biologic Medical Product Introduction
11.22.4 Sun Pharma Revenue in Biologic Medical Product Business (2018-2024)
11.22.5 Sun Pharma Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Biologic Medical Product Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Colony-Stimulating Factor
Table 4. Key Players of Interferon
Table 5. Key Players of Erythropoietin
Table 6. Key Players of Insulin
Table 7. Key Players of Vaccines
Table 8. Key Players of Growth Hormones
Table 9. Key Players of Others
Table 10. Global Biologic Medical Product Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 11. Global Biologic Medical Product Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 12. Global Biologic Medical Product Market Size by Region (2018-2024) & (US$ Million)
Table 13. Global Biologic Medical Product Market Share by Region (2018-2024)
Table 14. Global Biologic Medical Product Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 15. Global Biologic Medical Product Market Share by Region (2024-2029)
Table 16. Biologic Medical Product Market Trends
Table 17. Biologic Medical Product Market Drivers
Table 18. Biologic Medical Product Market Challenges
Table 19. Biologic Medical Product Market Restraints
Table 20. Global Biologic Medical Product Revenue by Players (2018-2024) & (US$ Million)
Table 21. Global Biologic Medical Product Revenue Share by Players (2018-2024)
Table 22. Global Top Biologic Medical Product by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologic Medical Product as of 2022)
Table 23. Global Biologic Medical Product Industry Ranking 2021 VS 2022 VS 2024
Table 24. Global 5 Largest Players Market Share by Biologic Medical Product Revenue (CR5 and HHI) & (2018-2024)
Table 25. Global Key Players of Biologic Medical Product, Headquarters and Area Served
Table 26. Global Key Players of Biologic Medical Product, Product and Application
Table 27. Global Key Players of Biologic Medical Product, Product and Application
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Biologic Medical Product Market Size by Type (2018-2024) & (US$ Million)
Table 30. Global Biologic Medical Product Revenue Market Share by Type (2018-2024)
Table 31. Global Biologic Medical Product Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 32. Global Biologic Medical Product Revenue Market Share by Type (2024-2029)
Table 33. Global Biologic Medical Product Market Size by Application (2018-2024) & (US$ Million)
Table 34. Global Biologic Medical Product Revenue Share by Application (2018-2024)
Table 35. Global Biologic Medical Product Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 36. Global Biologic Medical Product Revenue Share by Application (2024-2029)
Table 37. North America Biologic Medical Product Market Size by Type (2018-2024) & (US$ Million)
Table 38. North America Biologic Medical Product Market Size by Type (2024-2029) & (US$ Million)
Table 39. North America Biologic Medical Product Market Size by Application (2018-2024) & (US$ Million)
Table 40. North America Biologic Medical Product Market Size by Application (2024-2029) & (US$ Million)
Table 41. North America Biologic Medical Product Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. North America Biologic Medical Product Market Size by Country (2018-2024) & (US$ Million)
Table 43. North America Biologic Medical Product Market Size by Country (2024-2029) & (US$ Million)
Table 44. Europe Biologic Medical Product Market Size by Type (2018-2024) & (US$ Million)
Table 45. Europe Biologic Medical Product Market Size by Type (2024-2029) & (US$ Million)
Table 46. Europe Biologic Medical Product Market Size by Application (2018-2024) & (US$ Million)
Table 47. Europe Biologic Medical Product Market Size by Application (2024-2029) & (US$ Million)
Table 48. Europe Biologic Medical Product Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 49. Europe Biologic Medical Product Market Size by Country (2018-2024) & (US$ Million)
Table 50. Europe Biologic Medical Product Market Size by Country (2024-2029) & (US$ Million)
Table 51. China Biologic Medical Product Market Size by Type (2018-2024) & (US$ Million)
Table 52. China Biologic Medical Product Market Size by Type (2024-2029) & (US$ Million)
Table 53. China Biologic Medical Product Market Size by Application (2018-2024) & (US$ Million)
Table 54. China Biologic Medical Product Market Size by Application (2024-2029) & (US$ Million)
Table 55. Asia Biologic Medical Product Market Size by Type (2018-2024) & (US$ Million)
Table 56. Asia Biologic Medical Product Market Size by Type (2024-2029) & (US$ Million)
Table 57. Asia Biologic Medical Product Market Size by Application (2018-2024) & (US$ Million)
Table 58. Asia Biologic Medical Product Market Size by Application (2024-2029) & (US$ Million)
Table 59. Asia Biologic Medical Product Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 60. Asia Biologic Medical Product Market Size by Region (2018-2024) & (US$ Million)
Table 61. Asia Biologic Medical Product Market Size by Region (2024-2029) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Biologic Medical Product Market Size by Type (2018-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Biologic Medical Product Market Size by Type (2024-2029) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Biologic Medical Product Market Size by Application (2018-2024) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Biologic Medical Product Market Size by Application (2024-2029) & (US$ Million)
Table 66. Middle East, Africa, and Latin America Biologic Medical Product Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 67. Middle East, Africa, and Latin America Biologic Medical Product Market Size by Country (2018-2024) & (US$ Million)
Table 68. Middle East, Africa, and Latin America Biologic Medical Product Market Size by Country (2024-2029) & (US$ Million)
Table 69. Roche Company Details
Table 70. Roche Business Overview
Table 71. Roche Biologic Medical Product Product
Table 72. Roche Revenue in Biologic Medical Product Business (2018-2024) & (US$ Million)
Table 73. Roche Recent Developments
Table 74. Amgen Company Details
Table 75. Amgen Business Overview
Table 76. Amgen Biologic Medical Product Product
Table 77. Amgen Revenue in Biologic Medical Product Business (2018-2024) & (US$ Million)
Table 78. Amgen Recent Developments
Table 79. AbbVie Company Details
Table 80. AbbVie Business Overview
Table 81. AbbVie Biologic Medical Product Product
Table 82. AbbVie Revenue in Biologic Medical Product Business (2018-2024) & (US$ Million)
Table 83. AbbVie Recent Developments
Table 84. Pfizer Company Details
Table 85. Pfizer Business Overview
Table 86. Pfizer Biologic Medical Product Product
Table 87. Pfizer Revenue in Biologic Medical Product Business (2018-2024) & (US$ Million)
Table 88. Pfizer Recent Developments
Table 89. Sanofi-Aventis Company Details
Table 90. Sanofi-Aventis Business Overview
Table 91. Sanofi-Aventis Biologic Medical Product Product
Table 92. Sanofi-Aventis Revenue in Biologic Medical Product Business (2018-2024) & (US$ Million)
Table 93. Sanofi-Aventis Recent Developments
Table 94. Johnson & Johnson Company Details
Table 95. Johnson & Johnson Business Overview
Table 96. Johnson & Johnson Biologic Medical Product Product
Table 97. Johnson & Johnson Revenue in Biologic Medical Product Business (2018-2024) & (US$ Million)
Table 98. Johnson & Johnson Recent Developments
Table 99. Novo Nordisk Company Details
Table 100. Novo Nordisk Business Overview
Table 101. Novo Nordisk Biologic Medical Product Product
Table 102. Novo Nordisk Revenue in Biologic Medical Product Business (2018-2024) & (US$ Million)
Table 103. Novo Nordisk Recent Developments
Table 104. Eli Lilly Company Details
Table 105. Eli Lilly Business Overview
Table 106. Eli Lilly Biologic Medical Product Product
Table 107. Eli Lilly Revenue in Biologic Medical Product Business (2018-2024) & (US$ Million)
Table 108. Eli Lilly Recent Developments
Table 109. Novartis Company Details
Table 110. Novartis Business Overview
Table 111. Novartis Biologic Medical Product Product
Table 112. Novartis Revenue in Biologic Medical Product Business (2018-2024) & (US$ Million)
Table 113. Novartis Recent Developments
Table 114. Merck Company Details
Table 115. Merck Business Overview
Table 116. Merck Biologic Medical Product Product
Table 117. Merck Revenue in Biologic Medical Product Business (2018-2024) & (US$ Million)
Table 118. Merck Recent Developments
Table 119. Sun Company Details
Table 120. Sun Business Overview
Table 121. Sun Biologic Medical Product Product
Table 122. Sun Revenue in Biologic Medical Product Business (2018-2024) & (US$ Million)
Table 123. Sun Recent Developments
Table 124. 3sbio Company Details
Table 125. 3sbio Business Overview
Table 126. 3sbio Biologic Medical Product Product
Table 127. 3sbio Revenue in Biologic Medical Product Business (2018-2024) & (US$ Million)
Table 128. 3sbio Recent Developments
Table 129. Changchun High Tech Company Details
Table 130. Changchun High Tech Business Overview
Table 131. Changchun High Tech Biologic Medical Product Product
Table 132. Changchun High Tech Revenue in Biologic Medical Product Business (2018-2024) & (US$ Million)
Table 133. Changchun High Tech Recent Developments
Table 134. CP Guojian Company Details
Table 135. CP Guojian Business Overview
Table 136. CP Guojian Biologic Medical Product Product
Table 137. CP Guojian Revenue in Biologic Medical Product Business (2018-2024) & (US$ Million)
Table 138. CP Guojian Recent Developments
Table 139. Biotech Company Details
Table 140. Biotech Business Overview
Table 141. Biotech Biologic Medical Product Product
Table 142. Biotech Revenue in Biologic Medical Product Business (2018-2024) & (US$ Million)
Table 143. Biotech Recent Developments
Table 144. Gelgen Company Details
Table 145. Gelgen Business Overview
Table 146. Gelgen Biologic Medical Product Product
Table 147. Gelgen Revenue in Biologic Medical Product Business (2018-2024) & (US$ Million)
Table 148. Gelgen Recent Developments
Table 149. Innovent Company Details
Table 150. Innovent Business Overview
Table 151. Innovent Biologic Medical Product Product
Table 152. Innovent Revenue in Biologic Medical Product Business (2018-2024) & (US$ Million)
Table 153. Innovent Recent Developments
Table 154. Ganlee Company Details
Table 155. Ganlee Business Overview
Table 156. Ganlee Biologic Medical Product Product
Table 157. Ganlee Revenue in Biologic Medical Product Business (2018-2024) & (US$ Million)
Table 158. Ganlee Recent Developments
Table 159. United Laboratories Company Details
Table 160. United Laboratories Business Overview
Table 161. United Laboratories Biologic Medical Product Product
Table 162. United Laboratories Revenue in Biologic Medical Product Business (2018-2024) & (US$ Million)
Table 163. United Laboratories Recent Developments
Table 164. Teva Pharmaceutical Company Details
Table 165. Teva Pharmaceutical Business Overview
Table 166. Teva Pharmaceutical Biologic Medical Product Product
Table 167. Teva Pharmaceutical Revenue in Biologic Medical Product Business (2018-2024) & (US$ Million)
Table 168. Teva Pharmaceutical Recent Developments
Table 169. MYLAN Company Details
Table 170. MYLAN Business Overview
Table 171. MYLAN Biologic Medical Product Product
Table 172. MYLAN Revenue in Biologic Medical Product Business (2018-2024) & (US$ Million)
Table 173. MYLAN Recent Developments
Table 174. Sun Pharma Company Details
Table 175. Sun Pharma Business Overview
Table 176. Sun Pharma Biologic Medical Product Product
Table 177. Sun Pharma Revenue in Biologic Medical Product Business (2018-2024) & (US$ Million)
Table 178. Sun Pharma Recent Developments
Table 179. Research Programs/Design for This Report
Table 180. Key Data Information from Secondary Sources
Table 181. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biologic Medical Product Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Biologic Medical Product Market Share by Type: 2022 VS 2029
Figure 3. Monoclonal Antibodies Features
Figure 4. Colony-Stimulating Factor Features
Figure 5. Interferon Features
Figure 6. Erythropoietin Features
Figure 7. Insulin Features
Figure 8. Vaccines Features
Figure 9. Growth Hormones Features
Figure 10. Others Features
Figure 11. Global Biologic Medical Product Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 12. Global Biologic Medical Product Market Share by Application: 2022 VS 2029
Figure 13. Tumor Case Studies
Figure 14. Diabetes Case Studies
Figure 15. Cardiovascular Case Studies
Figure 16. Hemophilia Case Studies
Figure 17. Others Case Studies
Figure 18. Biologic Medical Product Report Years Considered
Figure 19. Global Biologic Medical Product Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 20. Global Biologic Medical Product Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 21. Global Biologic Medical Product Market Share by Region: 2022 VS 2029
Figure 22. Global Biologic Medical Product Market Share by Players in 2022
Figure 23. Global Top Biologic Medical Product Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologic Medical Product as of 2022)
Figure 24. The Top 10 and 5 Players Market Share by Biologic Medical Product Revenue in 2022
Figure 25. North America Biologic Medical Product Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. North America Biologic Medical Product Market Share by Type (2018-2029)
Figure 27. North America Biologic Medical Product Market Share by Application (2018-2029)
Figure 28. North America Biologic Medical Product Market Share by Country (2018-2029)
Figure 29. United States Biologic Medical Product Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Canada Biologic Medical Product Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Europe Biologic Medical Product Market Size YoY (2018-2029) & (US$ Million)
Figure 32. Europe Biologic Medical Product Market Share by Type (2018-2029)
Figure 33. Europe Biologic Medical Product Market Share by Application (2018-2029)
Figure 34. Europe Biologic Medical Product Market Share by Country (2018-2029)
Figure 35. Germany Biologic Medical Product Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. France Biologic Medical Product Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. U.K. Biologic Medical Product Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Italy Biologic Medical Product Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Russia Biologic Medical Product Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Nordic Countries Biologic Medical Product Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. China Biologic Medical Product Market Size YoY (2018-2029) & (US$ Million)
Figure 42. China Biologic Medical Product Market Share by Type (2018-2029)
Figure 43. China Biologic Medical Product Market Share by Application (2018-2029)
Figure 44. Asia Biologic Medical Product Market Size YoY (2018-2029) & (US$ Million)
Figure 45. Asia Biologic Medical Product Market Share by Type (2018-2029)
Figure 46. Asia Biologic Medical Product Market Share by Application (2018-2029)
Figure 47. Asia Biologic Medical Product Market Share by Region (2018-2029)
Figure 48. Japan Biologic Medical Product Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. South Korea Biologic Medical Product Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. China Taiwan Biologic Medical Product Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Southeast Asia Biologic Medical Product Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. India Biologic Medical Product Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Australia Biologic Medical Product Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Middle East, Africa, and Latin America Biologic Medical Product Market Size YoY (2018-2029) & (US$ Million)
Figure 55. Middle East, Africa, and Latin America Biologic Medical Product Market Share by Type (2018-2029)
Figure 56. Middle East, Africa, and Latin America Biologic Medical Product Market Share by Application (2018-2029)
Figure 57. Middle East, Africa, and Latin America Biologic Medical Product Market Share by Country (2018-2029)
Figure 58. Brazil Biologic Medical Product Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 59. Mexico Biologic Medical Product Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 60. Turkey Biologic Medical Product Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 61. Saudi Arabia Biologic Medical Product Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 62. Israel Biologic Medical Product Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 63. GCC Countries Biologic Medical Product Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 64. Roche Revenue Growth Rate in Biologic Medical Product Business (2018-2024)
Figure 65. Amgen Revenue Growth Rate in Biologic Medical Product Business (2018-2024)
Figure 66. AbbVie Revenue Growth Rate in Biologic Medical Product Business (2018-2024)
Figure 67. Pfizer Revenue Growth Rate in Biologic Medical Product Business (2018-2024)
Figure 68. Sanofi-Aventis Revenue Growth Rate in Biologic Medical Product Business (2018-2024)
Figure 69. Johnson & Johnson Revenue Growth Rate in Biologic Medical Product Business (2018-2024)
Figure 70. Novo Nordisk Revenue Growth Rate in Biologic Medical Product Business (2018-2024)
Figure 71. Eli Lilly Revenue Growth Rate in Biologic Medical Product Business (2018-2024)
Figure 72. Novartis Revenue Growth Rate in Biologic Medical Product Business (2018-2024)
Figure 73. Merck Revenue Growth Rate in Biologic Medical Product Business (2018-2024)
Figure 74. Sun Revenue Growth Rate in Biologic Medical Product Business (2018-2024)
Figure 75. 3sbio Revenue Growth Rate in Biologic Medical Product Business (2018-2024)
Figure 76. Changchun High Tech Revenue Growth Rate in Biologic Medical Product Business (2018-2024)
Figure 77. CP Guojian Revenue Growth Rate in Biologic Medical Product Business (2018-2024)
Figure 78. Biotech Revenue Growth Rate in Biologic Medical Product Business (2018-2024)
Figure 79. Gelgen Revenue Growth Rate in Biologic Medical Product Business (2018-2024)
Figure 80. Innovent Revenue Growth Rate in Biologic Medical Product Business (2018-2024)
Figure 81. Ganlee Revenue Growth Rate in Biologic Medical Product Business (2018-2024)
Figure 82. United Laboratories Revenue Growth Rate in Biologic Medical Product Business (2018-2024)
Figure 83. Teva Pharmaceutical Revenue Growth Rate in Biologic Medical Product Business (2018-2024)
Figure 84. MYLAN Revenue Growth Rate in Biologic Medical Product Business (2018-2024)
Figure 85. Sun Pharma Revenue Growth Rate in Biologic Medical Product Business (2018-2024)
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed